BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...

Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...

∙ As a first result of the exclusive negotiations initiated in July, the two companies sign a global distribution agreement ∙ After an initial payment of €4 million, BIOCORP receives a new payment of ...

PALO ALTO, Calif., Feb. 23, 2023 /PRNewswire/ -- Glooko Inc. ("Glooko"), today announced that they have entered into a partnering agreement with Sanofi to increase their support of people living with ...

NEW YORK Sanofi-aventis’ SoloSTAR insulin pen has some serious competition. Two independent studies in Germany and Japan have found that Novo Nordisk’s FlexPen was more accurate in delivering insulin ...

The FDA approves Sanofi's (NASDAQ:SNY) Toujeo (insulin glargine 300 Units/mL) Max SoloStar. The product holds 900 Units of Toujeo and can deliver up to 160 Units in a single injection. The company ...

Here's some welcome news for diabetics dealing with the high price of insulin: The Food and Drug Administration has approved Mylan (MYL +0.00%) and Biocon's Semglee, which is essentially identical to ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...